The Trump administration said Tuesday evening it's sending out 100 cease-and-desist letters to companies as part of a crackdown on what it called misleading direct-to-consumer ads.

The big picture: Meanwhile, President Trump signed a memorandum directing Health and Human Services Secretary Robert F. Kennedy Jr. to enforce transparency on pharmaceutical advertising, including increasing the amount of information in the ads about risks of using the drugs.

Zoom in: In addition to the cease-and-desist letters to companies that it says have "deceptive ads," the FDA said in a statement that it's sending "thousands of letters warning pharmaceutical companies to remove misleading ads." • And the Trump administration is closing a 1997 "loophole" that allowed drug ads to "footnote vital informat

See Full Page